Amyloid and Glucose Brain Imaging Research Study for People with and without Memory Problems
Please refer to this study by identifier 4863
Principal Investigator(s)
Davangere Devanand
Purpose
The PET scan involves the use of a radioactive marker, which is taken up by abnormal deposits, called amyloid deposits, which may be related to Alzheimer's disease. The PET camera will detect the signal it gives. A PET glucose scan and an MRI scan, which are standard clinical procedures, are also done in this research study.
Type of Study: Observational Type
Setting of Study: outpatient
Clinical Trials.gov number:
Providing Clinical Treatment?: No
Study Activities
Filling Out Forms
Blood Samples
PET Scan
MRI Scan
Provides Payment: Reimbursement for transportation
Provides Payment: Compensation for study related procedures
Eligibility
Ages Eligible for Study: 50 Years - 89 Years
Genders Eligible for Study: Both
This study is recruiting Healthy Volunteers.
Criteria
Location: 1051 Riverside Drive, Unit 126
New York, NY 10032
Clinic: Memory Disorders Clinic
Division: Biological Psychiatry
Study chairs or principal investigators:
Davangere P. Devanand M.D., Principal Investigator
Co-investigators:
John Mann,
J.S. Dileep Kumar,
Rikki Waterhouse,
Ramin Parsey,
Harold Sackheim
|
For more information, please contact
Katrina Cuasay
Tel: (212) 543-5025
E-mail: kc2035@columbia.edu
|
|